Interestingly, a better long-term improvement (change in MADRS at 1-year follow-up) for predominantly female patients with mild to moderate depression and high versus low plasma MIF levels was also reported for non-pharmacological treatment in a mindfulness-based group therapy setting with a similar, albeit non-significant, trend after 8 weeks [54]. The gene discussed is MIF; the disease is depressive disorder.